ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Banco do Brasil SA

Banco do Brasil SA (BBAS3)

28.30
0.06
(0.21%)
Cerrado 22 Marzo 2:55PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
28.30
Postura de Compra
28.28
Postura de Venta
28.48
Volume Operado de la Acción
66,960,300
28.07 Rango del Día 28.48
23.68 Rango de 52 semanas 29.63
Capitalización de Mercado [m]
Precio Anterior
28.24
Precio de Apertura
28.35
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
19,136,532
Acciones en circulación
5,730,834,040
Rendimiento del Dividendo
1.95%
Ratio Precio/Utilidad
4.58
Beneficio por acción (BPA)
6.18
turnover
143.4B
Beneficio neto
35.44B

Acerca de Banco do Brasil SA

Sector
Commercial Banks, Nec
Industria
Commercial Banks, Nec
Sitio web
Sede
Brasilia Df, Bra
Fundado
-
Banco do Brasil SA is listed in the Commercial Banks sector of the Brazil Bovespa Exchange with ticker BBAS3. The last closing price for BANCO DO BRASIL ON was R$28.24. Over the last year, BANCO DO BRASIL ON shares have traded in a share price range of R$ 23.68 to R$ 29.63.

BANCO DO BRASIL ON currently has 5,730,834,040 shares in issue. The market capitalisation of BANCO DO BRASIL ON is R$161.84 billion. BANCO DO BRASIL ON has a price to earnings ratio (PE ratio) of 4.58.

BBAS3 Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.772.7969487831527.5328.7427.531843924028.31196152CS
40.31.071428571432828.7426.741997367827.91852936CS
123.9616.269515201324.3429.6323.681913653227.18472359CS
260.82.9090909090927.529.6323.681928508826.36794917CS
520028.329.6323.681701915126.85624103CS
15611.467.455621301816.929.95515.1251470992223.20664107CS
26015.8126.412.529.95510.9551560186320.03027553CS

BBAS3 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de BANCO DO BRASIL ON?
El precio actual de las acciones de BANCO DO BRASIL ON es R$ 28.30
¿Cuántas acciones de BANCO DO BRASIL ON están en circulación?
BANCO DO BRASIL ON tiene 5,730,834,040 acciones en circulación
¿Cuál es la capitalización de mercado de BANCO DO BRASIL ON?
La capitalización de mercado de BANCO DO BRASIL ON es BRL 161.84B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de BANCO DO BRASIL ON?
BANCO DO BRASIL ON ha negociado en un rango de R$ 23.68 a R$ 29.63 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de BANCO DO BRASIL ON?
El ratio precio/beneficio de BANCO DO BRASIL ON es 4.58
¿Cuál es el ratio de efectivo a ventas de BANCO DO BRASIL ON?
El ratio de efectivo a ventas de BANCO DO BRASIL ON es 1.13
¿Cuál es la moneda de reporte de BANCO DO BRASIL ON?
BANCO DO BRASIL ON presenta sus resultados financieros en BRL
¿Cuál es el último ingresos anual de BANCO DO BRASIL ON?
El último ingresos anual de BANCO DO BRASIL ON es BRL 143.4B
¿Cuál es el último beneficio anual de BANCO DO BRASIL ON?
El último beneficio anual de BANCO DO BRASIL ON es BRL 35.44B
¿Cuál es la dirección registrada de BANCO DO BRASIL ON?
La dirección registrada de BANCO DO BRASIL ON es SAUN QUADRA 5 LOTE B, ED BANCO DO BRASIL 3 ANDAR, SETOR DE AUTARQUIAS, BRASILIA DF, 70040-912
¿Cuál es la dirección del sitio web de BANCO DO BRASIL ON?
La dirección del sitio web de BANCO DO BRASIL ON es www.bb.com.br
¿En qué sector industrial opera BANCO DO BRASIL ON?
BANCO DO BRASIL ON opera en el sector COMMERCIAL BANKS, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MOVI3Movida Participacoes SA
R$ 4.98
(12.93%)
22.13M
BHIA3Grupo Casas Bahia SA
R$ 7.89
(12.39%)
13.32M
LIGT3Light Sa
R$ 4.65
(12.32%)
3.93M
PTNT3Pettenati Sa Ind Textil
R$ 9.90
(11.86%)
4.3k
BMOB3Bemobi Tech S.A.
R$ 16.50
(10.00%)
1.62M
ZAMP3Zamp S.A.
R$ 2.40
(-14.89%)
11.59M
PLAS3Plascar Participacoes Industriais Sa
R$ 6.12
(-12.32%)
7k
AMOB3Automob Participacoes Sa
R$ 0.27
(-10.00%)
32.1M
MOAR3Monteiro Aranha Sa
R$ 270.00
(-9.40%)
700
MBLY3Mobly S.A.
R$ 1.10
(-9.09%)
473.4k
HAPV3Hapvida Participacoes Investimento SA
R$ 2.17
(-3.56%)
104.53M
BBAS3Banco do Brasil SA
R$ 28.30
(0.21%)
66.96M
BBDC4Bco Bradesco Sa
R$ 12.47
(1.38%)
64.82M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.72
(1.32%)
61.18M
CMIG4Cia Energetica Minas Gerais Cemig
R$ 10.82
(-4.92%)
56.8M
Krungster10 Krungster10 51 segundos hace
Sounds like you have some type of hero complex to think you are out here saving grown folks that are making their own financial decisions. Who are you to tell anyone what not to buy with their own money?
ASII
Truthsocial Truthsocial 54 segundos hace
Exactly absolutely
RDGL
Bigfootbud Bigfootbud 2 minutos hace
Ok, cool! Looks like trumpcancer.com has been registered since 7/25/2005!! Long time!

WHOIS search results
Domain Information
NameTRUMPCANCER.COMRegistry Domain ID189029673_DOMAIN_COM-VRSN
Registered On 2005-07-25 T 23:53:48Z
Expires On 2025-07-25 T 23:53
VRSN
fung_derf fung_derf 3 minutos hace
Keep howling at the moon Fung. Nobody is selling $DBMM.


Or buying it seems.
Therefore, no one need post here and yet here you are!
DBMM
Ayock Ayock 3 minutos hace
Your cult doesn't seem to care...

https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/485739739_1125751009656472_2638257754763246620_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=833d8c&_nc_ohc=HIFOXUeljRQQ7kNvgGrTA7E&_nc_oc=Adn0mhz5WMG-x509_zDcd6MVHfJ6fcxqBTy9s64GUlNo8agAot8eeruhg_067v4UsOBzoWnSo
Steady_T Steady_T 3 minutos hace
Once approval comes, your threatened lawsuit will be years before it could possibly have results, assuming it is not dismissed early on.

Not something I'm worried about at the present time.
NWBO
Bubae Bubae 4 minutos hace
D your really think anyone is buying that line. You will need to do better to flip your position. $11 a shares. Meanwhile the weekly conversions continue next week with a basis price of $0.0003. You think maybe they should be holding for $11.00. The price of ECVO at $11.00 is a very thinly and very
ASII
ddls ddls 4 minutos hace
Yes, thanks for all the BIEL-bullshit throughout the-years. 🤠

One more week and my March share volume comes out.

I can tell you as of current numbers they're not looking too good.

The pumpaholoic's better come up with something good this week or M
BIEL
WALLnut WALLnut 5 minutos hace
You wouldn’t know “keeping it real” if it smacked you in the face. Your entire argument is built on a deliberate misrepresentation of what makes a medical technology valuable.

Yes, RadioGel’s original patents are old—but you conveniently ignore the fact that Vivos has developed and se
RDGL
vuletini vuletini 7 minutos hace
Fake news
XRPUSD
hotmeat hotmeat 8 minutos hace
Not even close to being the same liar......you've been informed of this FACT repeatedly and yet you continue to maliciously promote this false narrative.

Good thing for us Vivos shareholders no one believes your incessant mindless drivel. lol
RDGL
fung_derf fung_derf 8 minutos hace
Why do Professors teach when they can do instead? Why do you hate educators so?
You talk of kids picking noses and people have no reason for educating.
Why are you so opposed to objectivity and balance on a board?
Did you get picked on a lot in school for being slow?
DBMM
Eagle1 Eagle1 10 minutos hace
Hope Everyone has a great and safe weekend!
GDVM
jondoeuk jondoeuk 12 minutos hace
It is too risky for IPSC, so I will watch from the sidelines. As for FATE, I will wait to see the data (FT819) that should be presented at the EULAR Congress, in June.
IPSC
sortagreen sortagreen 12 minutos hace
These are some rookie numbers here...

Three killed and 15 injured in New Mexico mass shooting
3 hours ago
Kayla Epstein

Three people were killed and 15 others injured in a mass shooting between two rival groups at an unsanctioned car show on Friday in the
Paulie Cashews Paulie Cashews 13 minutos hace
So, what's your problem with the ad? Seems like a good deal - just answer a few questions, and they'll send you a free Gift Card.

I'm sure they'll keep your Social Security number and credit card info safe and secure!

Or, you could pay up and buy an IHUB subscription, a
ksquared ksquared 13 minutos hace
California Dems nervous about Republicans speaking out — and possibly losing control
By Susan Shelley Published March 22, 2025, 11:00 a.m. ET Other Assembly Republicans were removed from their committees after such “offenses” as opposing the bullet train, warning that the state’s mishandl
manibiotech manibiotech 13 minutos hace
Except they don't have data on any of those cancers listed in the table to apply for an approval . Before you point to any early stage or phase 1 trials , I think my statement is clear about the data they can actually use to apply for an approval. 
NWBO
johnydollar johnydollar 14 minutos hace
Can one say it loud, myopic 👀........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹
DBMM
fung_derf fung_derf 15 minutos hace
Now, you can't state you're done posting here then start again.
For the record, I have never shorted a stock in my 30 years of investing. Even when I can see it would be the smart thing to do.
I also, don't take positions in penny stocks and shorting one seems silly considering all the
ERHE
SC8 SC8 15 minutos hace
How is Radiogel "groundbreaking" when it was invented over two decades ago, all the original patents have expired and RDGL has at least one competitor we know of that beat them to human trials back in 2022?

Just keeping it real.
RDGL
DTGoody DTGoody 16 minutos hace
AFFU Management if you are reading this message board put out some news and get your stock price back up to a respectable level! I am relativity new here, but you have longs who have toughed out the rough times with your company prior to Covid who deserve a lot better. For their sake do not screw ov
AFFU
WALLnut WALLnut 17 minutos hace
The Future of Cancer Treatment: Why RadioGel® Will Be a Game-Changer After IDE Approval and What’s Next for IsoPet®

RadioGel® is on the verge of redefining cancer treatment, especially for localized tumors that are difficult to remove surgically or treat with traditional radiation the
RDGL